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Abstract
The relationship between health care expenditure and health outcomes has been the subject
of recent academic inquiry in order to inform cost-e ectiveness thresholds for health technology
assessment agencies. Previous studies in public health systems have relied upon data aggregated 
at the national or regional level however there remains debate about whether the supply side e ect 
of changes to expenditure are identifiable using data at this level of aggregation. We use detailed
patient data derived from electronic neonatal records across England along with routinely available
cost data to estimate the e ect of changes to patient expenditure on clinical health outcomes in a
well-defined patient population. A panel of 32 neonatal intensive care units for the period 2009-
2013 was constructed. Accounting for the potential endogeneity of expenditure a £100 increase in 
the cost per intensive care cot day (sample average cost: £1,127) leads to a reduction in the risk of 
mortality of 0.38 percentage points (sample average mortality: 11.0%) in neonatal intensive care. 
This translates into a cost per life saved in neonatal intensive care of approximately £420,000.
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1 Introduction
Recent work in the United Kingdom and elsewhere has attempted to estimate the relationship 
between healthcare expenditure and health outcomes in order to inform cost-e ectiveness thresh- 
olds for health technology assessment (HTA) (Claxton et al., 2015, Vallejo-Torres et al., 2016).
Beyond the consideration about investment in new technologies and services, such studies are also
important to answer the question of whether the benefits of increased medical expenditure in gen-
eral are worth the additional cost. In this study, we estimate the returns to expenditure in neonatal
intensive care using individual patient-level data, which allows us to identify the level and type of
care an infant received. Previous studies have demonstrated clinically and economically significant
benefits of healthcare expenditure on patient outcomes (Martin et al., 2008, Cutler et al., 2006, Luce 
et al., 2006, Stukel et al., 2005, Claxton et al., 2015) and specifically in neonatal healthcare (Al-
mond et al., 2010). However, there remains significant variability between these estimates, which
may be due to di erences in the methods used, variations in expressions of the outputs of health- 
care, and use of aggregate versus individual level data. As an example of the observed variation,
estimates derived from di erent models of the cost per statistical life saved in neonatal care range
from $550,000 (approximately £330,000) (Almond et al., 2010) to £15 million (approximately $25 
million) (Claxton et al., 2015). Similarly significant variation exists in the estimates of the returns
to medical expenditure between alternative programmes of care within the same study (Claxton
et al., 2015).
It is perhaps unsurprising that such variation exists both within and between research projects. 
Even if each study presented precise and unbiased estimates of the e ect of interest, there would be 
heterogeneity between patient populations and the portfolio of technologies and labour inputs avail-
able to them. This has implications for the adoption of new medical technologies and decisions to
increase expenditure. For such decisions, the estimated incremental cost-e ectiveness is typically 
compared to a cost-e ectiveness threshold below which new technologies or policies are recom-
mended for reimbursement. Many authors have argued that the cost-e ectiveness threshold should
reflect the average changes in patient health outcomes when the healthcare budget has been con-
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tracted or expanded (Claxton et al., 2015). New technologies with an incremental cost-e ectiveness
below this threshold will be more cost-e ective on average than those services displaced and thus
improve overall healthcare e ciency. A better understanding of which services are displaced and 
whether that displacement is within or between programmes of care can further improve e ciency, 
and hence reliable evidence of the returns to expenditure for di erent care types is required.
For health care systems free at the point of use, such as the National Health Service (NHS)
in England and Wales, where individual expenditure data is not available, other methods such as 
comparing aggregate expenditure and outcomes are used, as demonstrated by (Martin et al., 2008,
Claxton et al., 2015). Such methods are being applied in other European countries and elsewhere.
However, it is di cult to identify the supply side e ect of shifts in the budget using data at the 
regional or national level as patient populations are not well defined between regions and over time.
Indeed, the aforementioned study by Claxton et al. (2015) was subject to a substantial critique
(Barnsley et al., 2013). In this study we present an alternative approach using a hospital-unit level
analysis and routinely collected cost data. We take a well-defined patient population, infants re-
ceiving neonatal intensive care, with well-defined providers, neonatal intensive care units. Using a 
panel of these units we identify the supply side e ect of shifts to the value of inputs to care. This
study provides methods that can be used for other care types while providing new estimates of the
return to medical expenditure for at-risk newborns.
2 Previous Literature
The relationship between health expenditure and patient outcomes is the subject of a large and 
growing literature (see Gallet and Doucouliagos (2016) for a recent review). In many instances 
the aim is to provide evidence towards an empirically derived cost-e ectiveness threshold for HTA 
(Gallet and Doucouliagos, 2016, Vallejo-Torres et al., 2016). In England and Wales, Claxton et al.
(2015), as well as the preceding work by Martin et al. (2008), estimated the value of the cost-
e ectiveness threshold in terms of the incremental cost per quality adjusted life year (QALY) gained
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using NHS Programme Budgeting Data. These data provide estimates of the expenditure on 23 pro-
grammes of healthcare within each of 152 local healthcare authorities. Using a number of socio- 
economic variables as instrumental variables for local healthcare authority expenditure, such as 
deprivation score and levels of unpaid care, to identify the e ect of expenditure on mortality rates,
the average estimated incremental cost per QALY gained was £12,936. With regards to outcomes
among neonates, Claxton et al. (2015) combined maternity and neonatal programmes of care into 
one category and assigned deaths to it on the basis of International Classification of Diseases, Ver-
sion 10 (ICD-10) codes recorded on death certificates. Various cross-sections of data from 2002
to 2008 were used. The authors state there were some issues assigning patients and deaths to pro-
grammes of care, for example, 94% of infant deaths (below one year of age) were re-assigned to 
programmes of care other than neonatal and maternity care even if they were treated in a neonatal
unit. The estimate of the incremental cost per life saved was approximately £3.4 million and incre-
mental cost per life year gained was approximately £45,0001—significantly larger than most other 
programmes of care, across which the average figures were £140,000 and £12,000, respectively.
In contrast, individual level neonatal data (used in this study) for 2009 to 2013 reveal that 98% of
infants that died in neonatal units were recorded as having neonatal ICD-10 codes.
Almond et al. (2010) estimated the marginal return to medical expenditure in a neonatal health- 
care setting. Using a regression discontinuity design, exploiting a discontinuity around treatment
provision to newborns either side of a 1,500g birth weight threshold, the authors estimated that
the cost of saving the life of a newborn with a birth weight around 1,500g was approximately
$550,000 (in 2006 US$). Nonetheless, this result is arguably not generalisable to the wider newborn
population given that only 4.1% of the admissions to neonatal specialist care are for infants with
birth weights within the bandwidth utilised in the study (data from the National Neonatal Research 
Database (NNRD; see Section 4.1); bandwidth 1,415-1,585g).
1These are the figures using 2006 expenditure data with 2006/7/8 outcomes data. The authors consider data is- 
sues extensively and provide estimates adjusted for factors such as di erential coverage of expenditure and outcomes 
data. The ‘coverage adjusted’ figures for incremental cost per life saved and incremental cost per life year gained were 
approximately £28 million and £30,000, respectively.
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3 Theoretical Framework
The health outcomes of a patient treated in hospital is a function of the labour (L) and capital 
(K ) inputs to their care along with underlying health at admission H . The labour and capital inputs 
are themselves functions of the patient’s health and vary between hospitals ( ) and over time (t):
health = f (g(L; K ); H )
L = L(H; ; t) 
K = K (H; ; t):
Interest lies in the identification of the e ect of increasing labour and capital inputs to a given 
patient’s care in terms of their health outcomes. Since these inputs are typically not observed, total
expenditure is often used as an overall measure of the cost of inputs. Since patients in worse health
are likely to receive greater inputs to their care, and the fact that health at admission cannot be fully 
observed, the use of expenditure data raises the issue of how to identify the supply side e ects of
inputs in this model. Similar econometric issues arise if patients are transferred to hospitals with
greater inputs to care. We focus on a well-defined patient population whose care requirements are 
clearly specified and relatively homogeneous.
This study focuses on two health outcomes of babies admitted to neonatal intensive care. These
are first, mortality and second, mobidity free survival. Neonatal care in England and Wales is
categorised into three principle levels of care. These are, from most to least intensive: intensive care
(IC), high dependency care (HDC), and special care (SC). Neonatal units are classified according to
the levels of care they provide, with only the highest level units providing IC. Units are organised into 
networks, which are comprised of units of all levels, and patients are transferred to units that provide 
higher levels of care if required (Gale et al., 2012). Patients do not have a choice over provider. 
The levels of care are defined by the treatments that the infant received (British Association of
Perinatal Medicine, 2011). As described below, a cot day at each level of care is a defined ‘unit’ of
treatment with known labour and capital inputs. The costs of these inputs are estimated by health
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care providers in the NHS and used to produce a national tari . Thus, changes to labour and capital 
inputs to an IC cot day should be more broadly reflective of changes to labour supply, for example, 
rather than shifts in the patient population.
4 Data and Sample
4.1 The National Neonatal Research Database
The National Neonatal Research Database (NNRD) was created by the Neonatal Data Analysis 
Unit (NDAU), a research unit based at Imperial College, London, and was established in 2006. The 
data are extracted from the individual, electronic patient records of infants treated within neonatal
units in England. The NDAU holds national research ethics committee approval to create this
database (reference REC 10/H0803/151) as well as the permission from the Caldicott Guardians of
each National Health Service (NHS) Trust. The data are psuedo-anonymised by removing patient
and maternal identifiers and encrypting the NHS number of each infant. The data include a large 
range of variables including static descriptive variables captured once per baby, such as birth weight 
and gestational age at birth, episodically, such as episodes of infection and other clinical outcomes, 
and daily items such as treatments and procedures as well as level of care.
4.1.1 Sample
From the NNRD, data were extracted on all infants born and discharged or died between January
1st 2009 and December 31st 2013, and who received at least one intensive care cot day. We restrict
our analysis to units designated to provide intensive care (neonatal intensive care units); intensive
care provided by lower designated units is therefore temporary or for stabilising an infant prior to 
transport and is likely to di er from ‘proper’ intensive care.
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4.2 NHS Reference Costs
The NHS Reference Costs data are estimates of the unit costs of providing healthcare across
all Healthcare Resource Groups (HRGs) in England. There are over 1,400 HRGs, which are clas-
sifications used in the NHS to categorise patients who consume the same level of resources, for 
example, a neonatal intensive care cot day. The estimated cost of providing one ‘unit’ of an HRG 
for each provider, i.e. NHS Trusts or NHS Foundation Trusts, is available as part of these data. The 
Department of Health uses these reference costs to set prices for NHS funded services in England.
The raw data at the provider level, used to calculate the average costs, were obtained for this study.
These data were not adjusted for local price di erences. Each provider estimates their cost for each 
HRG by taking into account fixed costs (e.g. depreciation), semi-fixed costs (e.g. nursing sta ),
and variable costs (e.g. drugs and consumables) (Monitor, 2014). These costs represent di erent
levels of factor inputs to the production of a predefined ‘unit’ of care and therefore represent an 
estimate of g(K ; L). Costs for an IC cot day do not include special or extraordinary treatments 
such as surgery or transfers between neonatal units.
5 Empirical Framework
The framework discussed in Section 3 suggests the following individual level model. The model
is specified at the individual level initially since data at this level enable us to identify which infants 
received intensive care, their outcomes, and various covariates predicting these outcomes.
Consider baby i admitted to the neonatal unit in hospital j in year t. Let yij t be the health
outcome, xij t a vector of exogenous characteristics explaining infant health, and exj t the cost per 
cot day in that unit. j , j t and t are unit, unit-year, and year fixed e ects, and uij t is an error term. 
The equation considered is the following multi-level specification:2
yij t = x0ij t + exj t + j + t + uij t : (1)
2Expenditure is specified in levels rather than natural logarithm both to facilitate calculation of the cost per life 
saved and as it is approximately normally distributed.
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The parameter of interest to this study is the average marginal e ect of health care expenditure on
infant health outcomes, . The labour and capital input data we use is the typical neonatal intensive 
care cot day per hosptal for the NHS Reference Costs data (as discussed above). We aggregate the 
above model to the level of the variable of interest; unit level outcomes are those of interest.3
At the aggregated level there is still concern that the average cost per IC cot day may be cor-
related with average unobserved di erences in patient casemix. Sicker infants are transferred to 
higher level units if required but it is plausible that the system of transfers is used to move in-
fants to units that are better resourced (Gale et al., 2012). While there is little evidence to suggest
this is taking place, we also consider an instrumental variables approach to estimation, to consider
the causal interpretation of our results. The location of a patient’s residence and the distance to 
the nearest hospital is likely to be conditionally independent of the characteristics of that hospi-
tal given local socioeconomic di erences—neonatal units located in more deprived areas may be
more likely to have a sicker casemix, since deprivation is correlated with infant health at birth, and 
therefore greater inputs to care. The patient is most likely to be treated in their nearest hospital. 
Thus, location provides a source of exogenous variation in hospital characteristics, conditional on
local socio-economic factors. This approach has been used in previous studies (Gowrisankaran and
Town, 1999, Geweke et al., 2003, Watson et al., 2014). In Section 3, which presents the theoreti-
cal framework, the instrument can be seen as providing exogenous variation in the unit providing 
treatment, . The average IC care day costs of the nearest hospital are used as an instrument for the 
costs at the place of birth. The first stage is also aggregated.4,5
We present results from both the fixed e ects (FE) estimator (i.e. within estimator) and the fixed
e ects instrumental variable estimator (FE-IV). Standard errors are clustered at the unit level.
3Infant-level variables are aggregated by taking the arithmetic mean within unit-years.
4The nearest neonatal unit, of any level, is determined by straight-line distance.
5Hausman and Taylor (1981) proposed a two-step method for the estimation of instrumental variable models where
the baby-level covariates are potentially correlated with unobserved e ect. However, we assume the baby-level covari- 
ates are exogenous in this model. The moment conditions required for validity of the instrumental variable method 
are assumed to be satisfied in this model, which implies they are satisfied at the aggregate level. Aggregation has the 
additional benefit of reducing the total number of moment conditions, the large number of which may bias the estimator 
at the individual level (Newey and Smith, 2004).
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5.1 Variable Definition
The outcome we consider is the in-hospital mortality rate defined as a percentage in between 0 
and 100. As a secondary outcome we consider a measure of ‘morbidity free survival’. A common
condition among neonates treated in IC is bronchopulmonary displasia (BPD), which is a chronic
lung condition associated with prematurity although normal term infants can su er from this as 
well (Ehrenkranz et al., 2005). We define morbidity free survival as 100 minus the percentage of
infants who survive to hospital discharge without BPD — in this way the outcome is also ‘negative’
like the primary outcome. The secondary outcome does not capture the full range of morbidities 
that an infant may su er from but provides an indication of the relationship between mortality and 
morbidity rates and inputs to IC. BPD is defined using data extracted from the NNRD.
The measure of expenditure is the cost per IC cot day (HRG ‘XA01Z’ above) in hundreds of
pounds. A number of exogenous determinants of in-hospital mortality are included. These are 
widely used in similar models (Medlock et al., 2011). The clinical variables included are gesta-
tional age, birth weight z-score,6 and dummies for whether an infant’s mother received antenatal
steroids and female sex. Dummies for region of residence are included along with indicators for
quintile of socio-economic deprivation for the mother’s home area derived from the Index of Mul-
tiple Deprivation (IMD). We also include the local market forces factor (MFF) as a covariate. The
MFF is estimated by the Department of Health and represents the unavoidable cost di erences in 
providing healthcare between areas, such as the cost of capital or labour inputs (Monitor, 2013).
Local price levels are also likely to be correlated with di erences in local socio-economic condi-
tions and hence infant health at birth. As a secondary analysis we re-estimate the model excluding 
the MFF and region and deprivation quintile indicators.
We consider a range of sensitivity analyses and checks for the robustness of the results to con-
sider the e ects of the various assumptions of the model and possible issues with the data. These 
are reported in Section 6.4.
6Birth-weight normalised within gestational age week.
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6 Results
6.1 Summary Statistics
Table 1 provides summary statistics for the sample of Neonatal Intensive Care (level three) 
neonatal units included in this study. Overall, 32 tertiary level neonatal units were included, which 
treated 7,979 infants who received at least one day of intensive care and from whom data was 
extracted. The mean (SD) cost per IC cot day across the sample was £1,198 (£367), which after 
adjustment for the MFF and in 2009 GBP was £1,127 (£315).
6.2 Instrumental Variable First Stage Results
Overall, 64% of infants in the sample were admitted to their nearest neonatal unit, and of those 
that were not, 71% did not have a neonatal unit designated to provide IC as their nearest unit. 89% of 
infants were admitted to a neonatal unit designated to provide IC in their nearest neonatal network. 
Table 2 reports the results from the first stage regression. An F-test of the instrumental variable
in the first stage regression provides strong evidence that the instrument is strongly correlated with
the cost variable. The estimated coe cient (standard error) was 1.11 (0.04), which supports the
hypothesis that increases in the costs per cot day at the nearest neonatal unit are associated with
increases in the cost per cot day at the hospital of birth. Indeed, the coe cient is greater than
one indicating that infants, on average, either receive treatment at their nearest neonatal unit or a
unit with greater costs per IC care day. There was little evidence to suggest that changes in the 
average composition of the casemix, as measured by various clinical variables, a ected the cost per 
IC care day. For example, the estimated coe cient for average gestational age was -0.24 (0.30),
which indicates that for every week reduction in average gestational age of the casemix the average
cost per cot day increases by £24. However, this is neither economically nor statistically significant.
Taken together this evidence may suggest that there is little correlation between unobserved casemix 
di erences and cost per IC cot day.
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6.3 E ect of Expenditure on Patient Outcomes
Table 3 reports the main results for infants who received at least one day of intensive care and 
who were inborn and treated in a neonatal intensive care unit with the proportion of those infants
who died in-hospital as the outcome. As indicated in the table, results from di erent models using
di erent controls are presented. Columns 1 and 2 do not include any controls. Addition of casemix 
(unit level averages of gestational age, birth weight z-score, female sex, multiple birth, and whether
a full or partial course of antenatal steroids was administered) and year controls (column 3) shows
evidence of a reduction in the mortality rate associated with increases to IC cot day costs suggesting 
units with higher risk patient casemixes have higher costs per IC cot day. The point estimate further
increases in magnitude with addition of area and socio-economic controls (column 4), implying
positive correlations between socio-economic characteristics of an area, the risk of mortality, and
the costs per IC cot day. Instrumenting the expenditure data (column 5) makes little di erence to 
the point estimate; the estimated coe cient is -0.38 (0.18) implying a £100 increase in the cost per 
cot day leads to a reduction in the mortality rate of 0.38 percentage points, ceteris parabis. This is 
approximately 3.5% of the overall mortality rate for this group of infants.
Table 4 reports the results with in-hospital mortality and/or bronchopulmonary dysplasia as the
outcome. These results are intended to provide an indication of whether the reductions observed 
in the mortality rate also translate into reductions in morbidity free survival. The point estimates 
for the models including all the controls are comparably smaller in magnitude than the equivalent
estimates for mortality despite 47% of the sample experiencing BPD and/or mortality. This suggests
reductions in the mortality rate are accompanied by equivalent rises in morbidity.
6.4 Robustness and Sensitivity Analyses
A number of sensitivity analyses were conducted to examine the robustness of results to the 
assumptions of the model. Firstly, the panel used in the main specification was unbalanced due 
to changes over years in the neonatal units contributing data to the NNRD. The unbalanced panel
may bias the estimators if units dropping out or joining the panel di er meaningfully from the other
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units. We therefore re-estimated the model using a balanced panel. Secondly, the time variable 
of the panel data is financial years, therefore some unit-year combinations have very few infants 
contributing if a unit’s participation varies by calendar year. We therefore re-estimated the model
dropping unit-years with fewer than ten infants. Thirdly, it is possible that the errors are serially
correlated, we therefore re-estimated using a first di erences estimator. Fourthly, an inspection of
the data (see Table 1) suggests that the year 2009/10 appears to di er from the other years in terms 
of case mix and outcomes. This could be due to temporal variations in definition of intensive care.
We re-estimated excluding this year as a further sensitivity analysis. Fifthly, there is a possibility
that selecting only infants who received IC may be endogenous if units vary their threshold to 
provide IC in response to changes in the cost per cot day. We re-estimated the model using infants
born extremely preterm (<29 weeks gestation). While not all of these infants receive IC, a high
proportion do (approximately 82% received IC in the NNRD data). Finally, we provide results 
from the individual level model specified in Equation (1) with unit-year average cost per cot day to 
examine the e ects of disaggregation.
Tables 5 and 6 report the results from the various sensitivity analyses. In comparison to the
primary result reported in column 5 of Table 3, Table 5 shows that the use of a balanced panel,
dropping observations aggregated from the data for a small number (<50) of infants, and using 
a first di erences estimator makes little qualitative di erence to the results. Turning to Table 6,
re-estimating the model using data from the financial year 2010/11 onwards only leads to a small
increase in the magnitude of the point estimate, potentially providing evidence to support the hy- 
pothesis for a shift in the definition or provision of IC between 2009 and 2010. Selecting the sample 
based upon gestational age rather than IC leads to a reduction in the magnitude of the point esti-
mates, which is unsurprising given approximately 20% of these infants did not receive IC and so
would be una ected directly by changes in the costs per IC cot day. Nevertheless, the estimated co-
e cients remain negative. Finally, columns 5 and 6 in Table 6 report the results from the individual
level model. The estimate from the FE model is qualitatively similar to that from the equivalent ag-
gregated model (column 4 of Table 3). However, the FE-IV estimate is quite di erent in magnitude
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and with greater uncertainty, but is still negative in sign. These results are reported for comparison 
but should be interpreted with the caveats discussed in Section 5.
7 Cost Per Life Saved
In this section, we derive a cost per life saved from the preceding results. These calculations 
are based on our principal result reported in column 5 of Table 3. This result is interpreted as a 
causal e ect resulting from exogenous increases to labour and capital inputs to an IC cot day. This 
includes, for example, improved sta to patient ratios, which we have previously shown to a ect 
the mortality rate in neonatal intensive care (Watson et al., 2016).
The neonatal units in the sample provided 122,305 IC care days over the course of the panel
(Table 1). It is estimated that a £100 increase in the cost per IC cot day results in a reduction in the
mortality rate of 0.36 percentage points [95% CI: -0.66, -0.07]. A £100 increase in the cost per IC 
cot day would cost £12,230,500 and result in approximately 29 [6, 53] fewer deaths thus suggesting 
that the cost per infant life saved at the margin is approximately £421,740 [£230,760, £2,038,420]. 
To convert the above estimates into an incremental cost per life year gained, the incremental 
cost per life saved can be divided by the number of life years gained. There are no suitable data
on the life expectancies of infants admitted to neonatal units given that the survival rate of very
preterm and preterm infants in the relatively recent past was very low. One option is to use the 
average life expectancy at birth for the English population today, which is approximately 81 years
(O ce for National Statistics, 2013). However, infants born in poor health, such as those born at a
low birth weight, have below average health, education, and labour market outcomes (Black et al.,
2007), which may suggest a reduced life expectancy for these infants. However, the life expectancy 
of an infant born today, and particularly one who survives the neonatal period, may be in excess of
81 years given reductions in mortality rates and improvements to public health and medical care.
We therefore utilise the average life expectancy of 81 years.7 This suggests a cost per life saved of
7This is also the strategy of Claxton et al. (2015) in their calculations.
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£5,210 per life year gained. The standard discount rate for benefits used by NICE is 3.5% (National
Institute for Health and Care Excellence, 2013). Using this rate gives an equivalent incremental 
cost per life year gained of £15,200.
These results are comparable to those from previous studies. Almond et al. (2010) estimated
that for infants weighing approximately 1,500g the cost per life saved was $550,000 in 2006 USD. 
This is qualitatively similar to the results from this study. Around 5% of the sample of infants in our
study were of the birthweights reported in Almond et al. (2010). Our estimates are lower than those
reported by Claxton et al. (2015) for neonatal and maternity care, who reported an incremental
cost per life year gained of approximately £200,000 using data from 2008 to 2010. However, they 
examined mortality outcomes for all infants who received neonatal care using aggregated data, the
majority of whom are at a very low risk of mortality. Increases in inputs to neonatal care among
infants at very low risk of mortality will likely be targeted at reducing morbidity and improving 
quality of life outcomes.
8 Conclusions
This study has examined the e ect of neonatal unit expenditure on an intensive care cot day
on the risk of mortality for infants receiving intensive care. Using these results, the incremental
cost per life saved in neonatal intensive care was estimated at approximately £420,000. Assuming
a 3.5% discount rate, this translates into an incremental cost per life year gained of £15,200. These 
results are comparable to a previous analysis of the returns to medical spending in at-risk newborns 
(Almond et al., 2010). However, they contrast with the higher estimates determined using regional 
expenditure and mortality rates in England for neonatal and maternity care (Claxton et al., 2015).
This may suggest that there is wide variation between programmes of care within the healthcare
service and indeed within a particular programme of care. With respect to the determination of an
appropriate cost-e ectiveness threshold this implies that whether a new technology would improve
e ciency is strongly dependent on where funding is displaced from. Furthermore, the returns to
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medical expenditure in areas where there is a very low mortality rate cannot be judged without data 
on relevant morbidity and quality of life outcomes.
This study has used data routinely available in the NHS to estimate the returns to medical ex-
penditure for a well-defined patient population to identify the supply side e ects of shifts in health
care expenditure. The method used in this study could be used across other types of care and in 
other patient populations for which patient data is available. This could provide important informa- 
tion for both cost-e ective investment and disinvestment strategies within the healthcare service.
However, the final estimates of incremental costs per life saved and life year gained are relatively
crude calculations. Life expectancy and quality of life outcomes of infants who received intensive
care is lacking. Further research is also required to estimate the benefits of increased expenditure to
infants not at the margin for the risk of mortality. Furthermore, reductions in the risk of mortality
can also be achieved by increasing the technical e ciency of units, such as by changing the choice
of factor inputs or the manner in which those inputs are employed. Further research is required to 
elucidate this. In the absence of published data we have not been able to adjust the incremental
cost per life year gained estimated for health related quality of life to convert the results into the
incremental cost per QALY gained, which would have been more useful for comparative purposes.
References
Almond, D., Doyle, Jr., J. J., Kowalski, A. E., and Williams, H. (2010). Estimating Marginal 
Returns to Medical Care: Evidence from At-Risk Newborns *. Quarterly Journal of Economics,
125(2):591–634.
Barnsley, P., Towse, A., Karlsberg Scha er, S., and Sussex, J. (2013). Critique of the CHE Research
Paper on NICE Thresholds.
Black, S. E., Devereux, P. J., and Salvanes, K. G. (2007). From the Cradle to the Labor Market? The 
E ect of Birth Weight on Adult Outcomes. The Quarterly Journal of Economics, 122(1):409–
439.
16
British Association of Perinatal Medicine (2011). Categories of Care 2011.
Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., Devlin, N., Smith, P. C., 
and Sculpher, M. (2015). Methods for the estimation of the National Institute for Health and
Care Excellence cost-e ectiveness threshold. Health Technology Assessment, 19:1–504.
Cutler, D. M., Rosen, A. B., and Vijan, S. (2006). The value of medical spending in the United
States, 1960-2000. The New England journal of medicine, 355(9):920–7.
Ehrenkranz, R. A., Walsh, M. C., Vohr, B. R., Jobe, A. H., Wright, L. L., Fanaro , A. A., Wrage,
L. A., and Poole, K. (2005). Validation of the National Institutes of Health consensus definition 
of bronchopulmonary dysplasia. Pediatrics, 116(6):1353–60.
Gale, C., Santhakumaran, S., Nagarajan, S., Statnikov, Y., and Modi, N. (2012). Impact of managed 
clinical networks on NHS specialist neonatal services in England: population based study. Bmj,
344(apr03 1):e2105–e2105.
Gallet, C. and Doucouliagos, C. (2016). The impact of healthcare spending on health outcomes: A
meta-regression analysis.
Geweke, J., Gowrisankaran, G., and Town, R. J. (2003). Bayesian Inference for Hospital Quality in
a Selection Model. Econometrica, 71(4):1215–1238.
Gowrisankaran, G. and Town, R. J. (1999). Estimating the quality of care in hospitals using instru-
mental variables. Journal of Health Economics, 18(6):747–767.
Hausman, J. A. and Taylor, W. E. (1981). Panel Data and Unobservable Individual E ects. Econo-
metrica, 49(6):1377–1398.
Luce, B. R., Mauskopf, J., Sloan, F. a., Ostermann, J., and Paramore, L. C. (2006). The return on 
investment in health care: from 1980 to 2000. Value in health : the journal of the International
Society for Pharmacoeconomics and Outcomes Research, 9(3):146–56.
17
Martin, S., Rice, N., and Smith, P. C. (2008). Does health care spending improve health outcomes? 
Evidence from English programme budgeting data. Journal of health economics, 27(4):826–42.
Medlock, S., Ravelli, A. C. J., Tamminga, P., Mol, B. W. M., and Abu-Hanna, A. (2011). Prediction 
of mortality in very premature infants: a systematic review of prediction models. PloS one,
6(9):e23441.
Monitor (2013). A guide to the Market Forces Factor. Technical report, NHS England, London. 
Monitor (2014). Approved Costing Guidance. Technical report, Monitor, London.
National Institute for Health and Care Excellence (2013). Guide to the methods of technology
appraisal 2013. Technical report, National Institute for Health and Care Excellence, London.
Newey, W. K. and Smith, R. J. (2004). Higher order properties of GMM and generalized empirical
likelihood estimators. Econometrica, 72(1):219–255.
O ce for National Statistics (2013). Historic and Projected Mortality Data from the Period and 
Cohort Life Tables, 2012-based, UK, 1981-2062. Technical report, O ce for National Statistics.
Stukel, T. A., Lucas, F. L., and Wennberg, D. E. (2005). Long-term Outcomes of Regional Varia- 
tions in Intensity of Invasive vs Medical With Acute Myocardial Infarction. 293(11):1329–1337.
Vallejo-Torres, L., García-Lorenzo, B., Castilla, I., Valcárcel-Nazco, C., García-Pérez, L., Liner- 
tová, R., Polentinos-Castro, E., and Serrano-Aguilar, P. (2016). On the Estimation of the Cost-
E ectiveness Threshold: Why, What, How? Value in Health.
Watson, S. I., Arulampalam, W., Petrou, S., Marlow, N., Morgan, A. S., Draper, E., and Modi,
N. (2016). The e ects of a one-to-one nurse-to-patient ratio on the mortality rate in neonatal
intensive care: a retrospective, longitudinal, population-based study. Archives of Disease in 
Childhood - Fetal and Neonatal Edition, 101(3):F195–F200.
Watson, S. I., Arulampalam, W., Petrou, S., Marlow, N., Morgan, a. S., Draper, E. S., Santhaku- 
maran, S., and Modi, N. (2014). The e ects of designation and volume of neonatal care on
18
mortality and morbidity outcomes of very preterm infants in England: retrospective population- 
based cohort study. BMJ Open, 4(7):e004856–e004856.
Conflicts of Interest
None declared.
Ethical Approval
This study was carried out with the National Neonatal Research Database (REC 10/H0803/151) 
with permission from NHS Trust Caldicott Guardians.
Funding
The Neonatal Data Analysis Unit is supported in part by a Programme Grant for Applied Re- 
search (RP-PG-0707-10010) from the National Institute of Health Research (NIHR) and has pre- 
viously received funding from the Department of Health and unrestricted funding from Danone,
AbbVie, and Abbott International. SW received funding from Bliss and the Department of Eco-
nomics, University of Warwick and is currently funded by NIHR Collaborations for Leadership in 
Applied Health Research and Care West Midland. The study funders had no role in study design,
collection, analysis, and interpretation of data, writing of the report, or in the decision to submit
the article for publication.
Acknowledgements
The authors would like to thank all of the neonatal units and unit leads participating in the 
Neonatal Economic, Sta ng, and Clinical Outcomes Project (NESCOP) and members of NESCOP
19
for insightful comments and analysis. The other members of NESCOP are Neena Modi, Neil Mar-
low, Elizabeth Draper, Andrei Morgan, and Andy Cole. The authors wish to thank Bliss and the 
Department of Economics, University of Warwick for generous financial support. In addition, the 
authors are grateful for helpful comments from Matt Sutton and Anne Spencer, two anonymous ref- 
erees, as well as participants at the European Health Economics Association (EuHEA) conference 
in 2014. The authors also wish to thank Eugene Statnikov, Shalini Santhakumaran, Daniel Gray,
Ahmadur Rahman, Cheryl Battersby, and Nicola Fitz-Simon at the Neonatal Data Analysis Unit for
valuable insight and advice as well as data management and processing. Finally, the authors would 
like to thank two anonymous referees for helpful and insightful comments.
20
Tables
Table 1: Summary statistics of the sample
Financial Year
Variable 2009/10 2010/11 2011/12 2012/13 Whole
Sample
N j 30 26 26 21
N i 1,378 2,406 2,752 1,443 7,979
Casemix
Birth weight (g) 1,743
(422)
Gestational age (weeks) 31.3
(2.3)
2,106
(208)
33.1
(1.1)
2,143
(212)
33.2
(1.1)
2,142
(247)
33.3
(1.2)
2,017
(340)
32.7
(1.8)
% male 46.4 42.5 44.4 45.0 44.7
Mortality (%) 7.5 13.4 11.4 13.0 11.0
Mortality and/or BPD 58.7 43.6 41.4 38.3 46.5
Costs
IC cot day cost (£) 1,145
(348)
IC cot day cost (£; MFF and inflation adjusteda) 1,126
(285)
Annual IC cot days (mean (SD)) 1,922
(1,031)
1,257
(388)
1,218
(368)
2,037
(1,067)
1,151
(356)
1,093
(324)
2,199
(1,238)
1,264
(388)
1,057
(283)
2,420
(1,157)
1,198
(367)
1,127
(315)
2,122
(1,119)
IC cot days (sample total) 24,530 35,554 29,279 22,943 122,305
Balanced Panel
N j 15 15 15 15
IC cot day cost (£) 1,147
(439)
IC cot day cost (£; MFF and inflation adjusteda) 1,117
(265)
1,335
(400)
1,277
(356)
1,226
(289)
1,146
(214)
1,298
(425)
1,090
(315)
1,252
(389)
1,158
(288)
a
N j is the number of neonatal units and N i is the number of infants.
Mortality is any in-hospital mortality.
Birth weight, gestational age, and unit costs are mean (SD) values.
These figures are adjusted for local market forces factor and are further adjusted to 2009/10 GBP using the Health 
Services Cost Index (HSCI).
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Table 2: Estimated coe cients from first stage regression
Coe cient Estimate Standard error
Gestational Age (weeks) -0.24 0.30
Full or partial course of antenatal steroids 0.05 2.17
Birth-weight z-score -0.52 0.77
2009/10 0.29 0.26
2010/11 0.18 0.18
2012/13 2.62 4.02
Female sex (%) -1.25 2.68
Multiple birth (%) -7.72 6.33
MFF -30.40 45.40
Instrument: Average IC cot day cost nearest hospital 1.11 0.04
F-statistics of excluded instruments 784.04
Kleibergen-Paap rk LM statistic 10.70
R2 0.96
N 104
Variables are aggregated to unit unit level by year by taking the arithmetic mean. Regressions also control 
for IMD quintile and region of residence of the infants.
p-value:  <0.05;  <0.01;  <0.001
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Table 3: Estimated e ect of increases to intensive care cot day costs on mortality
(1) (2) (3) (4) (5)
Mortality
OLS FE FE FE FE-IV
Expenditure 0.04 -0.00 -0.26 -0.38 -0.36
Standard error (0.16) (0.15) (0.16) (0.18) (0.15)
Casemix controls No No Yes Yes Yes
Year controls No No Yes Yes Yes
Area and SE controls No No No Yes Yes
Observations 104 104 104 104 104
OLS = ordinary least squares, FE = fixed e ects, FE-IV = instrumental variable fixed e ects
Casemix controls are averages of gestational age, birthweight z-score, female sex, multiple birth, and whether a 
full or partial course of antenatal steroids was administered. Year controls are dummies for year. Area and SE 
controls are proportions of infants whose maternal residence was in each deprivation quintile, proportions from 
each region, and the market forces factor.
p-value:  <0.05;  <0.01;  <0.001
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Table 4: Estimated e ect of increases to intensive care cot day costs on mortality and/or BPD
(1) (2) (3) (4) (5)
Mortality and/or bronchopulmonary dysplasia
OLS FE FE FE FE-IV
Expenditure 0.07 -0.30 -0.13 -0.24 -0.26
Standard error (0.36) (0.44) (0.17) (0.21) (0.17)
Casemix controls No No Yes Yes Yes
Year controls No No Yes Yes Yes
Area and SE controls No No No Yes Yes
Observations 104 104 104 104 104
OLS = ordinary least squares, FE = fixed e ects, FE-IV = instrumental variable fixed e ects.
Casemix controls are averages of gestational age, birthweight z-score, female sex, multiple birth, and whether a 
full or partial course of antenatal steroids was administered. Year controls are dummies for year. Area and SE 
controls are proportions of infants whose maternal residence was in each deprivation quintile, proportions from 
each region, and the market forces factor.
p-value:  <0.05;  <0.01;  <0.001
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